Cancer Molecular Pathology of School of Medicine, Griffith University, Gold Coast, Queensland, Australia.
Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, Bangladesh.
Methods Mol Biol. 2020;2129:241-257. doi: 10.1007/978-1-0716-0377-2_18.
MicroRNAs (miRNAs) are 20-22 nucleotides long single-stranded noncoding RNAs. They regulate gene expression posttranscriptionally by base pairing with the complementary sequences in the 3'-untranslated region of their targeted mRNA. Aberrant expression of miRNAs leads to alterations in the expression of oncogenes and tumor suppressors, thereby affecting cellular growth, proliferation, apoptosis, motility, and invasion capacity of gastrointestinal cells, including cells of esophageal squamous cell carcinoma (ESCC). Thus, alterations in miRNAs expression associated with the pathogenesis and progression of ESCC. In addition, expression profiles of miRNAs correlated with various clinicopathological factors, including pathological stages, histological differentiation, invasion, metastasis of cancer, as well as survival rates and therapy response of patients with ESCC. Consequently, expression profiles of miRNAs could be useful as diagnostic, prognostic, and prediction biomarkers in ESCC. Herein, we describe the quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and microarray methods for detection and quantitate miRNAs in ESCC. In addition, we summarize the roles of miRNAs in ESCC pathogenesis, progression, and prognosis.
微小 RNA(miRNAs)是 20-22 个核苷酸长的单链非编码 RNA。它们通过与靶 mRNA 的 3'-非翻译区互补序列碱基配对,在后转录水平上调节基因表达。miRNAs 的异常表达导致癌基因和肿瘤抑制基因表达的改变,从而影响胃肠道细胞(包括食管鳞状细胞癌(ESCC)细胞)的细胞生长、增殖、凋亡、运动和侵袭能力。因此,miRNAs 表达的改变与 ESCC 的发病机制和进展有关。此外,miRNAs 的表达谱与各种临床病理因素相关,包括病理分期、组织学分化、侵袭、转移以及 ESCC 患者的生存率和治疗反应。因此,miRNAs 的表达谱可以作为 ESCC 的诊断、预后和预测生物标志物。本文描述了用于检测和定量 ESCC 中 miRNAs 的实时定量逆转录聚合酶链反应(qRT-PCR)和微阵列方法。此外,我们总结了 miRNAs 在 ESCC 发病机制、进展和预后中的作用。